Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04047719 · ClinicalTrials.gov registry record
Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens
A clinical trial, sponsored by Karius.
- Completed
- Registry status
- 257
- Enrollment target
NCT04047719 is a clinical trial that has completed, run by Karius. The registered enrollment target is 257 participants.
The verdict
NCT04047719 has completed, sponsored by Karius.
- COMPLETED
- Registry status
- 257 participants
- Enrollment target
Study Summary
Given the need for a more sensitive pathogen detection test in patients with immunocompromised pneumonia, this study will evaluate the performance of the Karius Test, a novel NGS blood test for the diagnosis of infectious diseases. We will compare the performance of the Karius Test to the results of microbiologic tests obtained as part of usual care for immunocompromised patients undergoing evaluation for suspected pneumonia.
Interventions
- DIAGNOSTIC_TEST Karius Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2019-11-05 |
| Est. Completion | 2022-06-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04047719
The ClinicalTrials.gov registry entry for NCT04047719 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Karius, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Karius Test is the first listed.
NCT04047719 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04047719 about?
NCT04047719 is a clinical study titled "Pneumonia in the ImmunoCompromised - Use of the Karius Test for the Detection of Undiagnosed Pathogens". Given the need for a more sensitive pathogen detection test in patients with immunocompromised pneumonia, this study will evaluate the performance of the Karius Test, a novel NGS blood test for the diagnosis of infectious diseases. We will compare the performance of the Karius Test to the results of...
What is the current status of trial NCT04047719?
This trial is currently completed. The enrollment target is 257 participants. The study started on 2019-11-05. Estimated completion is 2022-06-06.
What interventions are being tested in trial NCT04047719?
The interventions under investigation include: Karius Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04047719?
This trial is sponsored by Karius, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.